Palliation of cancer in human patients by maintenance therapy with NN'N"-triethylene thiophosphoramide and N-(3-oxapentamethylene)-N'N"-diethylene phosphoramide.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms; D010166:Palliative Care; D063088:Phosphoramides; D013852:Thiotepa
D000970:Antineoplastic Agents; D063088:Phosphoramides; C005438:phosphoramide; D013852:Thiotepa
CYTOTOXIC DRUGS/therapeutic use